Skip to content
Screener

Integra LifeSciences IART Q3 2025 earnings

Reported October 30, 2025 · Before market open

Revenue$402.1MMiss by $27.6M
EPS$0.54Beat by $0.11
Revenue estimate$429.6M
EPS estimate$0.43

Next report

Oct 29, 2026 (in a month)
Revenue estimate$416.3M
EPS estimate$0.56

Financials

Q3 2025

Income statement

See full
Revenue$402.1M+5.6%
Gross profit$207.0M+3.4%
Operating income$11.8M+244%
Net income-$5.4M+49.5%
EPS (diluted)-$0.07+50.0%

Balance sheet

See full
Cash & equivalents$232.2M+7.9%
Total debt$1.9B0.0%
Total equity$1.0B-31.8%
Total assets$3.6B-10.3%

Cash flow

See full
Operating cash flow$40.9M+81.9%
CapEx$15.2M-48.9%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.12B-20.6%
Enterprise value$2.81B-9.8%
P/S0.7×-0.2×

Profitability

See full
Gross margin52.3%-2.6pp
Operating margin-29.3%-31.1pp

Returns & leverage

See full
Debt / equity1.9×+0.6×
Current ratio3.1×+1.9×

Segments

By product

See full
Neurosurgery$201.6M+14.6%
Wound Reconstruction$84.0M+4.4%
Instruments$50.2M-7.5%
ENT$40.9M+0.7%
Private Label$25.5M-13.9%

By geography

See full
Europe$42.9M+24.8%
Asia Pacific$42.7M+15.2%
Rest of World$20.6M—

FAQ

When did Integra LifeSciences report Q3 2025 earnings?
Integra LifeSciences (IART) reported Q3 2025 earnings on October 30, 2025 before market open.
What were Integra LifeSciences's Q3 2025 revenue and EPS?
Integra LifeSciences reported revenue of $402.1M and eps of $0.54 for Q3 2025.
Did Integra LifeSciences beat estimates in Q3 2025?
Revenue missed the consensus estimate of $429.6M by $27.6M. EPS beat the consensus estimate of $0.43 by $0.11.
How did Integra LifeSciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.6% from $380.8M a year earlier and eps grew 31.7% from $0.41.
Where can I find Integra LifeSciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0000917520-25-000094) and the 10-Q periodic report (0000917520-25-000096) directly on SEC EDGAR. The filing index links above go to sec.gov.